Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
ASCO Annual Meeting 2026 · Chicago, IL
8 shown of 6,778 total abstracts
  1. Abstract 100012026-06-05 · 13:30 CT · Arie Crown Theater
    Real-world effectiveness of Opdivo vs standard of care in metastatic melanoma
    C. Robert, M. Krop, H. Borghaei · National Cancer Center Japan
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  2. Abstract 97722026-06-03 · 13:45 CT · Hall B1
    Quality of life outcomes with Opdivo in patients with metastatic melanoma
    C. Saura, H. Borghaei, L. Paz-Ares · Stanford Cancer Institute
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  3. Abstract 103052026-06-04 · 16:45 CT · S100A
    Long-term follow-up of Opdivo maintenance for metastatic melanoma: CheckMate-454
    L. Paz-Ares, C. Saura, F. Andre, et al. · Chinese University of Hong Kong
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  4. Abstract 102942026-06-03 · 20:00 CT · Hall B1
    CheckMate-262: Opdivo (nivolumab) maintenance in metastatic melanoma
    H. Rugo, N. Rizvi, F. Andre · Royal Marsden Hospital
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  5. Abstract 96652026-06-01 · 13:00 CT · S406
    Keytruda plus chemotherapy in previously untreated metastatic melanoma: updated analysis from KEYNOTE-498
    N. Rizvi, F. Andre · Mayo Clinic
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  6. Abstract 100122026-06-03 · 14:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Keytruda in metastatic melanoma (the KEYNOTE-978 study)
    M.C. Garassino, S. Tolaney, C. Saura, et al. · University of Chicago
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  7. Abstract 97572026-06-04 · 20:45 CT · S100A
    Long-term follow-up of Opdivo 3L+ for metastatic melanoma: CheckMate-269
    P. Schmid, A. Spira · Dana-Farber Cancer Institute
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
  8. Abstract 101532026-06-02 · 16:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Opdivo in metastatic melanoma (the CheckMate-623 study)
    M.C. Garassino, L. Paz-Ares, A. Spira, et al. · University of Chicago
    Rapid Oral Abstract SessionMelanoma📄🖼️🎬
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.